Regenerative Cell Therapy for Corneal Endothelium.

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Therapy

Background:

• Corneal endothelial dysfunction, seen in Fuchs dystrophy and pseudophakic bullous keratopathy, necessitates corneal transplantation.
• Limited availability of donor corneas fuels research into cell-based therapies.
• Human corneal endothelial cells (HCECs) have a restricted capacity for regeneration.

Purpose of the Study:

• To explore cell therapy as a regenerative alternative to traditional corneal transplantation.
• To address challenges in ex vivo expansion and molecular identification of functional HCECs.
• To investigate novel cell delivery techniques for corneal endothelial regeneration.

Main Methods:

• Investigating stimulation of endogenous progenitors for HCEC regeneration.
• Developing methods for ex vivo expansion of donor-derived HCECs.
• Evaluating techniques such as injection and artificial corneal scaffolds for cell delivery.

Main Results:

• Cell therapy, including stem cell-derived or expanded HCECs, shows potential to replace conventional surgery.
• Ex vivo expansion of HCECs presents technical difficulties.
• Effective molecular identification of functional HCECs remains an area for development.
• Various cell delivery methods are under investigation.

Conclusions:

• Corneal endothelial cell therapies represent the future of treating corneal endotheliopathies.
• Despite challenges in cell expansion and delivery, clinical translation is advancing.
• Regenerative approaches offer a viable alternative to corneal transplants.